期刊文献+

肿瘤靶向治疗药物的应用与评价 被引量:3

Evaluation of Drugs Used for Cancer Target Therapy
暂未订购
导出
摘要 目的:评价肿瘤靶向治疗药物的疗效和安全性,以供临床用药参考。方法:通过对肿瘤靶向治疗药物的上市情况和临床应用对其作用机制、临床疗效和对肿瘤治疗模式的影响加以评价。结果与结论:分子新靶点药物具有可使肿瘤治疗变得有明显的针对性,其治疗方式亦可更加简便,避免细胞毒药物的多药耐药性,改善肿瘤患者的生活质量等优点;但也存在很多亟待解释的问题。 OBJECTIVE: To evaluate curative effect and safety of drugs used for cancer target therapy, in order to give some references for clinical drug use. METHODS: By analyzing the condition of going on sale and clinical application of drugs used for cancer target therapy, to evaluate their mechanism of action, clinical curative effect and the effect on cancer therapy mode. RESULTS & CONCLUSION : Molecule new target drugs have some merits,they can make cancer therapy have more evident pertinency, therapy mode more convenient, avoid multidrug resistance of cytotoxic drugs and improve life quality of cancer patients. However, there still exist some urgent problems to be solved.
出处 《中国医院用药评价与分析》 2005年第4期208-211,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 癌症 靶向治疗 适应证 疗效 不良反应 作用机制 cancer target therapy indication curative effect side effect mechanism of action
  • 相关文献

参考文献23

  • 1Ross JS,Schenkein DP,Pietrusko R,et al.Targeted therapies for cancer 2004 [J].Am J Clin Pathol,2004,122(4) :598.
  • 2FDA.A catalog of FDA approved drug products[ DB].http :∥www.accessdata .fda.gov / scripts / cder / drugsatfda ,2005.
  • 3U.S.Department of Health and Human Services.First monoclonal antibody approved to treat cancer[ EB/OL].http :∥www .fda.gov/bbs/topics/NEWS/NEW00601.html ,1997,12,26.
  • 4U.S.Department of Health and Human Services.New monoclonal antibody approved for advanced breast cancer [ EB/OL ].http :∥www.fda.gov/bbs/topics/NEWS/NEW00655.html ,1998,9,25.
  • 5FDA.FDA approves eribitux for colorectal cancer[ EB/OL].http :∥ www .fda.gov/ bbs/ topics/ NEWS/2004/ NEW01024.html ,2004 ,2 ,12 .
  • 6FDA.FDA approves first angiogenesis inhibitor to treat colorectal cancer [EB/OL] .http:∥www.fda.gov/bbs / topics/NEWS/2004/ NEW0 1027.html ,2004,2,26.
  • 7Czuczman MS,Grillo Lopez AJ,White CA,et al.Treatment of patients with low- grade B - cell lymphoma with the combination of chimeric anti - CD20 monoclonal antibody and CHOP chemotherapy[J].J Clin Oncol,1999,17( 1 ) :268.
  • 8Baselga J,Tripathy D,Mendelsohn J,et al.Phase Ⅱ study of weekly intravenous trastuzumab (herceptin) in patients with HER2/neu - overexpressing metastatic breast cancer [J].Semin Oncology,1999,26(4 Suppl 12):78.
  • 9Morishima Y,Ogura M,Nishimura M,et al.Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia:results of a Japanese phase Ⅱclinical study[J].Int J Hematol,2004 ,80 ( 3 ) :261.
  • 10Heinrich MC,Blanke CD,Druker BJ,et al.Inhibition of KITtyrosine kinase activity:a novel molecular approach to the treatment of KIT - positive malignancies [J].J Clin Oncol,2002,20(6):1 692.

同被引文献18

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部